Hasil Pencarian - Ravi Vij

Perbaiki Hasil
  1. 1
    Preparing for a “Haplo” Tsunami in India

    Preparing for a “Haplo” Tsunami in India oleh Ravi Vij

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome

    Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome oleh Thomas Fong, Ravi Vij, Anitha Vijayan, John DiPersio, Morey Blinder

    Diterbitkan 2007-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study

    Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study oleh Hira Mian, Tanya M. Wildes, Ravi Vij, Matthew J. Pianko, Ajay Major, Mark A. Fiala

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf.

    Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf. oleh Chelsea D Mullins, Mack Y Su, Vishwanathan Hucthagowder, Liang Chu, Lan Lu, Shashikant Kulkarni, Deborah Novack, Ravi Vij, Michael H Tomasson

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

    Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies oleh David Siegel, Thomas Martin, Ajay Nooka, R. Donald Harvey, Ravi Vij, Ruben Niesvizky, Ashraf Z. Badros, Sundar Jagannath, Leanne McCulloch, Kanya Rajangam, Sagar Lonial

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma

    PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma oleh Barbara Muz, Maurizio Buggio, Feda Azab, Pilar de la Puente, Mark Fiala, Mahesh V. Padval, David T. Weaver, Jonathan A. Pachter, Ravi Vij, Abdel Kareem Azab

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow

    Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow oleh Dhruv Bansal, Kiran Vij, Gue Su Chang, Christopher A. Miller, John F. DiPersio, Ravi Vij, Sharon E. Heath, Peter Westervelt, John S. Welch, Todd A. Fehniger

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

    A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma oleh Kinan Alhallak, Amanda Jeske, Pilar de la Puente, Jennifer Sun, Mark Fiala, Feda Azab, Barbara Muz, Ilyas Sahin, Ravi Vij, John F. DiPersio, Abdel Kareem Azab

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma

    Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stro... oleh Pilar de la Puente, Nancy Quan, Ryan Soo Hoo, Barbara Muz, Rebecca C. Gilson, Micah Luderer, Justin King, Samuel Achilefu, Noha Nabil Salama, Ravi Vij, Abdel Kareem Azab

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

    Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM oleh Sandy Wong, Habib Hamidi, Luciano J. Costa, Selma Bekri, Natalia Neparidze, Ravi Vij, Tina G. Nielsen, Aparna Raval, Rajan Sareen, Elisabeth Wassner-Fritsch, Hearn J. Cho, Hearn J. Cho

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY

    P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY oleh Karthik Ramasamy, Hartmut Goldschmidt, Philippe Moreau, Maria-Teresa Petrucci, David Kuter, Brian Durie, David Cella, Devender Dhanda, Jin Gu, Suvina Amin, Thomas Marshall, Pallavi Patwardhan, Susan Fish, Ravi Vij

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Evolution and structure of clinically relevant gene fusions in multiple myeloma

    Evolution and structure of clinically relevant gene fusions in multiple myeloma oleh Steven M. Foltz, Qingsong Gao, Christopher J. Yoon, Hua Sun, Lijun Yao, Yize Li, Reyka G. Jayasinghe, Song Cao, Justin King, Daniel R. Kohnen, Mark A. Fiala, Li Ding, Ravi Vij

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia

    Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leuke... oleh Bruno C. Medeiros, Kelly McCaul, Suman Kambhampati, Daniel A. Pollyea, Rajat Kumar, Lewis R. Silverman, Andrea Kew, Lalit Saini, CL Beach, Ravi Vij, Xiwei Wang, Jim Zhong, Robert Peter Gale

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

    Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival oleh Deep Hathi, Chantiya Chanswangphuwana, Nicholas Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey, Julie O’Neal, Anchal Ghai, Kathleen Duncan, Walter J. Akers, Mark Fiala, Ravi Vij, John F. DiPersio, Michael Rettig, Monica Shokeen

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

    Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide oleh Scott R. Goldsmith, Michael Slade, John F. DiPersio, Peter Westervelt, Steven J. Lawrence, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Erik R. Dubberke, Kathryn Trinkaus, Rizwan Romee

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

    Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia oleh Ramzi Abboud, Ezhilarasi Chendamarai, Michael P. Rettig, Kathryn M. Trinkaus, Peter A. Riedell, Camille N. Abboud, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States

    Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States oleh Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Michel Delforge, Nirali Kotowsky, Jacopo Bitetti, Natalie Boytsov, Leena Camadoo-O'Byrne, Lindsey Powers Happ, Guillaume Germain, Ana Urosevic, Malena Mahendran, Mei Sheng Duh, Francois Laliberte, Michele Cavo, Hans C. Lee

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE

    PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE oleh Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Michel Delforge, Nirali Kotowsky, Jacopo Bitetti, Natalie Boytsov, Leena Camadoo-O’byrne, Lindsey Powers Happ, Mujib Rohman, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    #27. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging

    #27. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging oleh Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen, Farrokh Dehdashti

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.

    Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types. oleh Sarah R Amend, William C Wilson, Liang Chu, Lan Lu, Pengyuan Liu, Daniel Serie, Xinming Su, Yalin Xu, Dingyan Wang, Anthony Gramolini, Xiao-Yan Wen, Julie O'Neal, Michelle Hurchla, Celine M Vachon, Graham Colditz, Ravi Vij, Katherine N Weilbaecher, Michael H Tomasson

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: